These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 30813333)

  • 1. Advances in Therapeutic Implications of Inorganic Drug Delivery Nano-Platforms for Cancer.
    Naz S; Shamoon M; Wang R; Zhang L; Zhou J; Chen J
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inorganic nanoparticles for cancer imaging and therapy.
    Huang HC; Barua S; Sharma G; Dey SK; Rege K
    J Control Release; 2011 Nov; 155(3):344-57. PubMed ID: 21723891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Progress in Delivery of Therapeutic and Imaging Agents Utilizing Organic-Inorganic Hybrid Nanoparticles.
    Haque ST; Chowdhury EH
    Curr Drug Deliv; 2018; 15(4):485-496. PubMed ID: 29165073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
    Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.
    Elzoghby AO; Hemasa AL; Freag MS
    J Control Release; 2016 Dec; 243():303-322. PubMed ID: 27794493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential for layered double hydroxides-based, innovative drug delivery systems.
    Zhang K; Xu ZP; Lu J; Tang ZY; Zhao HJ; Good DA; Wei MQ
    Int J Mol Sci; 2014 Apr; 15(5):7409-28. PubMed ID: 24786098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double layered hydroxides as potential anti-cancer drug delivery agents.
    Riaz U; Ashraf SM
    Mini Rev Med Chem; 2013 Apr; 13(4):522-9. PubMed ID: 23170959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inorganic nanoparticle-based drug codelivery nanosystems to overcome the multidrug resistance of cancer cells.
    Chen Y; Chen H; Shi J
    Mol Pharm; 2014 Aug; 11(8):2495-510. PubMed ID: 24224544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric nanoparticles for cancer therapy.
    Parveen S; Sahoo SK
    J Drug Target; 2008 Feb; 16(2):108-23. PubMed ID: 18274932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming the stability, toxicity, and biodegradation challenges of tumor stimuli-responsive inorganic nanoparticles for delivery of cancer therapeutics.
    Paris JL; Baeza A; Vallet-Regí M
    Expert Opin Drug Deliv; 2019 Oct; 16(10):1095-1112. PubMed ID: 31469003
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy.
    Lim EK; Chung BH; Chung SJ
    Curr Drug Targets; 2018 Feb; 19(4):300-317. PubMed ID: 27262486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate loaded self stabilized calcium phosphate nanoparticles: a novel inorganic carrier for intracellular drug delivery.
    Mukesh U; Kulkarni V; Tushar R; Murthy RS
    J Biomed Nanotechnol; 2009 Feb; 5(1):99-105. PubMed ID: 20055112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles.
    Gautier J; Allard-Vannier E; Munnier E; Soucé M; Chourpa I
    J Control Release; 2013 Jul; 169(1-2):48-61. PubMed ID: 23567046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Delivery of Chemotherapeutic Agents for Cancer Treatment.
    Yadav A; Singh S; Sohi H; Dang S
    AAPS PharmSciTech; 2021 Dec; 23(1):25. PubMed ID: 34907501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hollow Inorganic Nanoparticles as Efficient Carriers for siRNA Delivery: A Comprehensive Review.
    Varshosaz J; Taymouri S
    Curr Pharm Des; 2015; 21(29):4310-28. PubMed ID: 26323421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor.
    Li X; Wu M; Pan L; Shi J
    Int J Nanomedicine; 2016; 11():93-105. PubMed ID: 26766908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inorganic nanomaterials for bioimaging, targeted drug delivery and therapeutics.
    Liang R; Wei M; Evans DG; Duan X
    Chem Commun (Camb); 2014 Nov; 50(91):14071-81. PubMed ID: 24955443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.